Tower Research Capital LLC (Trc) Revolution Medicines, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $4.87 Billion
  • Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 18,479 shares of RVMD stock, worth $690,190. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,479
Previous 2,392 672.53%
Holding current value
$690,190
Previous $108,000 648.15%
% of portfolio
0.02%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$42.97 - $60.6 $691,258 - $974,872
16,087 Added 672.53%
18,479 $808,000
Q3 2024

Nov 14, 2024
SELL
$36.92 - $47.94 $873,601 - $1.13 Million
-23,662 Reduced 90.82%
2,392 $108,000
Q2 2024

Aug 13, 2024
BUY
$30.14 - $40.68 $742,679 - $1 Million
24,641 Added 1743.88%
26,054 $1.01 Million
Q1 2024

May 15, 2024
SELL
$26.56 - $33.55 $189,425 - $239,278
-7,132 Reduced 83.46%
1,413 $45,000
Q4 2023

Feb 13, 2024
SELL
$18.35 - $34.12 $222,879 - $414,421
-12,146 Reduced 58.7%
8,545 $245,000
Q3 2023

Nov 14, 2023
BUY
$25.17 - $35.05 $446,666 - $621,997
17,746 Added 602.58%
20,691 $572,000
Q2 2023

Aug 14, 2023
SELL
$20.28 - $27.0 $9,592 - $12,771
-473 Reduced 13.84%
2,945 $78,000
Q1 2023

May 09, 2023
BUY
$20.76 - $30.09 $30,745 - $44,563
1,481 Added 76.46%
3,418 $74,000
Q4 2022

Feb 10, 2023
SELL
$17.68 - $25.53 $70,967 - $102,477
-4,014 Reduced 67.45%
1,937 $46,000
Q3 2022

Nov 10, 2022
SELL
$17.46 - $26.0 $6,425 - $9,568
-368 Reduced 5.82%
5,951 $117,000
Q2 2022

Aug 15, 2022
SELL
$14.54 - $27.17 $16,284 - $30,430
-1,120 Reduced 15.06%
6,319 $123,000
Q1 2022

May 12, 2022
SELL
$17.31 - $26.4 $761 - $1,161
-44 Reduced 0.59%
7,439 $190,000
Q4 2021

Feb 14, 2022
BUY
$24.35 - $33.7 $34,503 - $47,752
1,417 Added 23.36%
7,483 $188,000
Q3 2021

Nov 15, 2021
BUY
$23.95 - $33.41 $44,235 - $61,708
1,847 Added 43.78%
6,066 $167,000
Q2 2021

Aug 16, 2021
BUY
$29.0 - $47.44 $63,104 - $103,229
2,176 Added 106.51%
4,219 $134,000
Q1 2021

May 17, 2021
SELL
$37.21 - $54.43 $67,722 - $99,062
-1,820 Reduced 47.11%
2,043 $94,000
Q4 2020

Feb 16, 2021
SELL
$30.19 - $45.49 $192,732 - $290,408
-6,384 Reduced 62.3%
3,863 $153,000
Q3 2020

Nov 16, 2020
BUY
$22.61 - $34.8 $167,766 - $258,215
7,420 Added 262.47%
10,247 $357,000
Q2 2020

Aug 13, 2020
BUY
$19.65 - $39.34 $55,550 - $111,214
2,827 New
2,827 $89,000

Others Institutions Holding RVMD

# of Institutions
297
Shares Held
168M
Call Options Held
920K
Put Options Held
1.06M
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.28B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email